Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07574346
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell MalignanciesPeking University People's HospitalNot Yet RecruitingEarly Phase 1
NCT07574346Not Yet Recruiting
Early Phase 1
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell MalignanciesPeking University People'...
NCT07573904
Comparative Effects of Posture Correction Exercises and Papworth Technique in Asthmatic Forward Head PostureRiphah International UniversityCompletedNot Applicable
NCT07573904Completed
Not Applicable
Comparative Effects of Posture Correction Exercises and Papworth Technique in As...Riphah International Univ...
NCT07573215
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic AdenocarcinomaRevolution Medicines, Inc.Unknown
NCT07573215Unknown
—
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metast...Revolution Medicines, Inc...
NCT07573592
Clinical Evaluation of an Atopic Skin Product Containing Picea Abies Resin ExtractBusiness FinlandCompletedNot Applicable
NCT07573592Completed
Not Applicable
Clinical Evaluation of an Atopic Skin Product Containing Picea Abies Resin Extra...Business Finland
NCT07573150
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing TonsillectomyNational Institute on Drug Abuse (NIDA)Not Yet Recruiting
NCT07573150Not Yet Recruiting
—
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Dep...National Institute on Dru...
NCT07573111
Open-label, Single Ascending Dose Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell TransplantationLaguna Biotherapeutics, Inc.Not Yet RecruitingPhase 1
NCT07573111Not Yet Recruiting
Phase 1
Open-label, Single Ascending Dose Study of QUAIL-100 in Pediatric and Young Adul...Laguna Biotherapeutics, I...
NCT07573878
Combined Effects of Neurodynamics With PNF on Pain and ROM in Patients With CTS.Riphah International UniversityCompletedNot Applicable
NCT07573878Completed
Not Applicable
Combined Effects of Neurodynamics With PNF on Pain and ROM in Patients With CTS.Riphah International Univ...
NCT07574424
Normative Values For Physical FitnessRiphah International UniversityEnrolling By Invitation
NCT07574424Enrolling By Invitation
—
Normative Values For Physical FitnessRiphah International Univ...
NCT07572929
A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic TransplantMedical College of WisconsinNot Yet RecruitingPhase 2
NCT07572929Not Yet Recruiting
Phase 2
A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Meas...Medical College of Wiscon...
NCT07573462
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy InfantsPfizerNot Yet RecruitingPhase 3
NCT07573462Not Yet Recruiting
Phase 3
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy...Pfizer
NCT07572851
Functional Changes and Fall Risk in Older Adults Participating in a Frailty ProgramUniversity of VigoEnrolling By Invitation
NCT07572851Enrolling By Invitation
—
Functional Changes and Fall Risk in Older Adults Participating in a Frailty Prog...University of Vigo
NCT07572513
Slowly Digestible Carbohydrates for GLP-1 SecretionPurdue UniversityRecruitingNot Applicable
NCT07572513Recruiting
Not Applicable
Slowly Digestible Carbohydrates for GLP-1 SecretionPurdue University
NCT07574047
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.Swiss Cancer InstituteNot Yet RecruitingPhase 4
NCT07574047Not Yet Recruiting
Phase 4
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for...Swiss Cancer Institute
NCT07573449
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Male ParticipantsOtsuka Pharmaceutical Development & Commercialization, Inc.CompletedPhase 1
NCT07573449Completed
Phase 1
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Si...Otsuka Pharmaceutical Dev...
NCT07572383
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPhase 2
NCT07572383Recruiting
Phase 2
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibros...National Heart, Lung, and...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07574073
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related CytopeniaQi dengNot Yet RecruitingPhase 1
NCT07574073Not Yet Recruiting
Phase 1
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refrac...Qi deng
NCT07574320
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel SyndromeMd. Aminul IslamNot Yet RecruitingPhase 4
NCT07574320Not Yet Recruiting
Phase 4
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel Syndr...Md. Aminul Islam
NCT07573059
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated PatientsImmedica Pharma US IncRecruitingNot Applicable
NCT07573059Recruiting
Not Applicable
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Pati...Immedica Pharma US Inc
NCT07572344
EFFECTS OF VIRTUAL REALITY TRAINING ON ATHLETIC PERFORMANCE IN PROFESSIONAL FOOTBALL PLAYERSRecep Tayyip Erdogan UniversityCompletedNot Applicable
NCT07572344Completed
Not Applicable
EFFECTS OF VIRTUAL REALITY TRAINING ON ATHLETIC PERFORMANCE IN PROFESSIONAL FOOT...Recep Tayyip Erdogan Univ...
Result Breakdown
Not yet recruiting9 (45%)
Completed5 (25%)
Recruiting3 (15%)
Enrolling by invitation2 (10%)
Unknown1 (5%)
not_applicable7 (35%)
Not Specified4 (20%)
Phase 13 (15%)
Phase 22 (10%)
Phase 42 (10%)
Early Phase 11 (5%)
Phase 31 (5%)